Cargando…

Effects of Lipid Lowering Therapies on Vulnerable Plaque Features: An Updated Narrative Review of the Literature

The clinical evidence on the efficacy of lipid lowering therapy in patients with coronary artery disease (CAD) is unequivocally established. However, the effects of these therapies on plaque composition and stability are less clear. The use of intracoronary imaging (ICI) technologies has emerged as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biccirè, Flavio Giuseppe, Gatto, Laura, La Porta, Ylenia, Pignatelli, Pasquale, Prati, Francesco, Pastori, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299518/ https://www.ncbi.nlm.nih.gov/pubmed/37367425 http://dx.doi.org/10.3390/jcdd10060260

Ejemplares similares

Correction to: D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2021)

Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

Present and future of coronary risk assessment
por: Prati, Francesco, et al.
Publicado: (2021)

Relationship between non-invasively detected liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

The risk of acute coronary events in microvascular disease
por: Varrichione, Giuseppe, et al.
Publicado: (2022)

Identification Markers of Carotid Vulnerable Plaques: An Update
por: Wang, Yilin, et al.
Publicado: (2022)

Non-culprit ruptured vulnerable plaque healing and stabilization by an aggressive lipid-lowering therapy
por: Shoji, Keisuke, et al.
Publicado: (2021)

Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits
por: van Hoof, Raf H. M., et al.
Publicado: (2017)

SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020)

Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines
por: Pastori, Daniele, et al.
Publicado: (2021)

Thrombosis in pre- and post-vaccination phase of COVID-19
por: Violi, Francesco, et al.
Publicado: (2021)

Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report
por: Menichelli, Danilo, et al.
Publicado: (2023)

CT imaging features of carotid artery plaque vulnerability
por: Murgia, Alessandro, et al.
Publicado: (2020)

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review
por: Violi, Francesco, et al.
Publicado: (2016)

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
por: Violi, Francesco, et al.
Publicado: (2016)

Contrast-Enhanced Ultrasound Feasibility in Assessing Carotid Plaque Vulnerability—Narrative Review
por: Kopyto, Ewa, et al.
Publicado: (2023)

Novel ultrasound techniques in the identification of vulnerable plaques—an updated review of the literature
por: Yao, Yujuan, et al.
Publicado: (2023)

Vulnerable atherosclerotic plaque features: findings from coronary imaging
por: Kurihara, Osamu, et al.
Publicado: (2021)

Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach
por: Pastori, Daniele, et al.
Publicado: (2019)

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
por: Pastori, Daniele, et al.
Publicado: (2019)

Effects of Serum Lipid Smoothness on the Progression and Vulnerability of Atherosclerotic Plaques in Rabbits
por: Zou, Xiao, et al.
Publicado: (2014)

Neuroimaging of the Vulnerable Plaque
por: Lovblad, Karl-Olof, et al.
Publicado: (2015)

Sudden cardiac death in ischaemic heart disease: coronary thrombosis or myocardial fibrosis?
por: Prati, Francesco, et al.
Publicado: (2023)

High-Risk Coronary Plaque Features: A Narrative Review
por: Dawson, Luke P., et al.
Publicado: (2022)

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management
por: Pignatelli, Pasquale, et al.
Publicado: (2020)

Imaging the Vulnerable Carotid Plaque with CT: Caveats to Consider. Comment on Wang et al. Identification Markers of Carotid Vulnerable Plaques: An Update. Biomolecules 2022, 12, 1192
por: Rotzinger, David C., et al.
Publicado: (2023)

Acute Coronary Syndrome with Non-Obstructive Plaque on Angiography and Features of Vulnerable Plaque on Intracoronary Optical Coherence Tomography
por: Dall’Orto, Clarissa Campo, et al.
Publicado: (2023)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis
por: Violi, Francesco, et al.
Publicado: (2020)

The impact of lipid-lowering medications on coronary artery plaque characteristics
por: Pulipati, Vishnu Priya, et al.
Publicado: (2021)

Clinical and Histopathological Features of Scleroderma-like Disorders: An Update
por: Foti, Rosario, et al.
Publicado: (2021)

Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy
por: Natsui, Hiroyuki, et al.
Publicado: (2022)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Age-related increase of thromboxane B(2) and risk of cardiovascular disease in atrial fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Multiple Arterial Thrombosis in Seronegative Antiphospholipid Syndrome: Need for New Diagnostic Criteria?
por: Pastori, Daniele, et al.
Publicado: (2019)

Clinical Phenotypes of Atrial Fibrillation and Mortality Risk—A Cluster Analysis from the Nationwide Italian START Registry
por: Pastori, Daniele, et al.
Publicado: (2022)

The incomplete circle of Willis is associated with vulnerable intracranial plaque features and acute ischemic stroke
por: Wang, Huiying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qjbekvk124mc77uflo17sg0kin